Variable expression of Dkc1 mutations in mice

Genesis

Volumn 47, Issue 6, 2009, Pages 366-373

  He, Jun ^a   Gu, Bai Wei ^a   Ge, Jingping ^a   Mochizuki, Yuko ^a   Bessler, Monica ^a   Mason, Philip J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow failure; Dyskerin; Ribosome biogenesis; SnoRNA; Telomerase

Indexed keywords

ALANINE; DYSKERIN; GLUTAMIC ACID; GLYCINE; RNA; VALINE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CHIMERA; CONTROLLED STUDY; DISEASE SEVERITY; DYSKERATOSIS CONGENITA; EMBRYO; FEMALE; FERTILITY; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENE TRANSFER; GENETIC TRAIT; HETEROZYGOTE; LIFESPAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION;

ANIMALS; BLOOD CELL COUNT; CELL CYCLE PROTEINS; CROSSES, GENETIC; DYSKERATOSIS CONGENITA; FEMALE; FERTILITY; GENE EXPRESSION; GENE TARGETING; GENOTYPE; HUMANS; LINKAGE (GENETICS); LONGEVITY; MALE; MICE; MICE, INBRED C57BL; MUTATION, MISSENSE; NUCLEAR PROTEINS; TIME FACTORS; X CHROMOSOME;

ANIMALIA; MUS;

EID: 70349191633     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20509     Document Type: Article

References (28)

1. Blackburn EH. 2005. Telomeres and telomerase: Their mechanisms of action and the effects of altering their functions. FEBS Lett 579:859-862.
2. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34.
3. Dokal I. 2000. Dyskeratosis congenita in all its forms. Br J Haematol 110:768-779.
4. Drachtman RA, Alter BP. 1995. Dyskeratosis congenita. Dermatol Clin 13:33-39.
5. Gu BW, Bessler M, Mason PJ. 2008. A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc Natl Acad Sci USA 105:10173-10178.
6. Hamma T, Reichow SL, Varani G, Ferre-D'Amare AR. 2005. The Cbf5-Nop10 complex is a molecular bracket that organizes box H/ACA RNPs. Nat Struct Mol Biol 12:1101-1107.
7. He J, Navarrete S, Jasinski M, Vulliamy T, Dokal I, Bessler M, Mason PJ. 2002. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene 21:7740-7744.
8. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I. 1998. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 19:32-38.
9. Knight SW, Heiss NS, Vulliamy TJ, Greschner S, Stavrides G, Pai GS, Lestringant G, Varma N, Mason PJ, Dokal I, Poustka A. 1999. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet 65:50-58.
10. Li L, Ye K. 2006. Crystal structure of an H/ACA box ribonucleoprotein particle. Nature 443:302-307.
11. Liu Y, Kha H, Ungrin M, Robinson MO, Harrington L. 2002. Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc Natl Acad Sci USA 99:3597-3602.
12. Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK. 1999. Thymosin β4 accelerates wound healing. J Invest Dermatol 113:364-368.
13. Meier UT. 2005. The many facets of H/ACA ribonucleoproteins. Chromosoma 114:1-14.
14. Mitchell JR, Cheng J, Collins K. 1999a. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol Cell Biol 19:567-576.
15. Mitchell JR, Wood E, Collins K. 1999b. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402:551-555.
16. Mochizuki Y, He J, Kulkarni S, Bessler M, Mason PJ. 2004. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci USA 101:10756-10761.
17. Pogacic V, Dragon F, Filipowicz W. 2000. Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol Cell Biol 20:9028-9040.
18. Ramamurthy V, Swann SL, Paulson JL, Spedaliere CJ, Mueller EG. 1999. Critical aspartic acid residues in pseudouridine synthases. J Biol Chem 274:22225-22230.
19. Rashid R, Liang B, Baker DL, Youssef OA, He Y, Phipps K, Terns RM, Terns MP, Li H. 2006. Crystal structure of a Cbf5-Nop10-Gar1 complex and implications in RNA-guided pseudouridylation and dyskeratosis congenita. Mol Cell 21:249-260.
20. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, Cordon-Cardo C, Pandolfi PP. 2003. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299:259-262.
21. Spedaliere CJ, Hamilton CS, Mueller EG. 2000. Functional importance of motif I of pseudouridine synthases: Mutagenesis of aligned lysine and proline residues. Biochemistry 39:9459-9465.
22. Vulliamy TJ, Dokal I. 2008. Dyskeratosis congenita: The diverse clinical presentation of mutations in the telomerase complex. Biochimie 90:122-130.
23. Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. 2006. Mutations in dyskeratosis congenita: Their impact on telomere length and the diversity of clinical presentation. Blood 107:2680-2685.
24. Wong JM, Collins K. 2006. Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev 20:2848-2858.
25. Wong JM, Kyasa MJ, Hutchins L, Collins K. 2004. Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum Genet 115:448-455.
26. Yoon A, Peng G, Brandenburger Y, Zollo O, Xu W, Rego E, Ruggero D. 2006. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312:902-906.
27. Zebarjadian Y, King T, Fournier MJ, Clarke L, Carbon J. 1999. Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA. Mol Cell Biol 19:7461-7472.
28. Zhu L, Hathcock KS, Hande P, Lansdorp PM, Seldin MF, Hodes RJ. 1998. Telomere length regulation in mice is linked to a novel chromosome locus. Proc Natl Acad Sci USA 95:8648-8653.